Nostrilla Nasal Decongestant Recall: Bacterial Contamination
More than 34,000 bottles of Nostrilla nasal decongestant have been pulled from the market because they may have bacterial contamination.
The Nostrilla recall was announced on October 19, by the FDA and the manufacturers, Insight Pharmaceuticals, after internal investigations discovered excessive amounts of the bacteria Burkholderia cepacia. There have been no illnesses reported in connection with the contaminated nasal decongestant.
The recall affects one lot of Nostrilla Nasal Decongestant consisting of 34,092 1/2 ounce plastic bottles. The bottles will be labeled with lot # 11G075 and an expiration date of 05/2014 stamped on the side. The bottles were distributed nationwide in pharmacies and retail outlets.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
The effects of a Burkholderia Cepacia infection may vary widely. While some individuals may exhibit no symptoms at all, others could experience serious respiratory infections. The bacteria has also been known to cause “foot-rot” among soldiers though it is more commonly associated with the development of serious health conditions in individuals with cystic fibrosis (CF) and those with chronic lung disease.
For individuals with existing health problems, Burkholderia Cepacia can attack the lungs and deterioration may be gradual or accelerated depending on the health of the person and on the type of Burkholderia Cepacia. In some cases, the bacteria could lead to pneumonia and death.
The FDA and Insight Pharmaceuticals recommend that any consumers who purchased Nostrilla Nasal Decongestant from the affected lot contact the company at 1-877-546-9059 and return the product.
Anyone who experiences an adverse reaction should contact their physician or healthcare provider. The FDA requests that any adverse reactions also be reported to the FDA’s MedWatch adverse event reporting program.
DavidDecember 10, 2013 at 6:39 pm
Used Nostrilla from 1985 till 2011 , worked very well for me till 2011 have purchased it since then and had all manner of sinus trouble with it, discontinued use in Nov 2013.I now use SinuFrin. Dont bother calling Nostrilla they wont talk to you. Even had a couple of bottles that smelled like Windex.Yes Windex. DONT BUY THIS PRODUCT AND DONT EVEN THINK ABOUT PUTTING IT UP YOUR NOSE.
mike sullivanOctober 25, 2011 at 5:29 am
This explains why I have been so stuffed up hopefully I can find out how to treat it now
SherineOctober 23, 2011 at 6:33 pm
Now this make sense !!I have been using this product for years and I purchase my last one fron CVS a few weeks ago, each time that I used it I kept saying there is a unusual odour from this spray , last night I called my husband and told him that I was extreamly stuff and it seems my sinus was acting up but I didnt want to use the spray I have because of smell and my shortness of breath .My reque[Show More]Now this make sense !!I have been using this product for years and I purchase my last one fron CVS a few weeks ago, each time that I used it I kept saying there is a unusual odour from this spray , last night I called my husband and told him that I was extreamly stuff and it seems my sinus was acting up but I didnt want to use the spray I have because of smell and my shortness of breath .My request to him was to purchase another one for me. He later called me back and said I have been to CVS, Walgreens and Winn Dixie and the shelf is empty, this bben said he purchased another brand. I was a little skeptical about his findings and decided I would google 'Nostrilla" and was startled when I saw this article. I immediately looked at the bottle I had in my position and yes I had a bottle from the batch that has been recalled!!!
"*" indicates required fields
More Top Stories
Defendants want to divide the discovery process to focus on the causal links between hair relaxers and cancer.
The FDA has announced it has received 106,000 medical device reports linked to recalled Philips CPAP devices, including nearly 400 deaths.
The U.S. JPML has consolidated all Tepezza lawsuits over hearing loss before one Northern Illinois federal judge for coordinated pretrial proceedings.